Attached files
| file | filename |
|---|---|
| 8-K - CURRENT REPORT - Tanke Biosciences Corp | f8k121913_tanke.htm |
Exhibit 16.1
| 19 West 44th Street, 12th Floor New York, NY 10036-6101 |
||
|
Phone
|
212-381-4700
|
|
|
Fax
|
212-381-4811
|
|
|
Web
|
www.uhy-us.com
|
|
December 26, 2013
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Commissioners:
We have read the statements made by Tanke Biosciences Corporation (copy attached), which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 4.01 of Form 8-K, as part of the Form 8K of Tanke Biosciences Corporation dated December 26, 2013. We agree with the statements concerning our Firm in such Form 8-K.
Very truly yours,
UHY LLP
An Independent Member of Urbach Hacker Young International